Sopherion Therapeutics Raises $55 Million
Sopherion Therapeutics LLC, a Princeton, N.J.-based developer of anti-cancer therapeutics, has raised $55 million in Series C funding led by Zoticon BioVentures. It previously raised $73 million, from firms like Sprout Group, ProQuest, Canaan Partners, HealthCap, NewSpring Ventures, Commerce Health Ventures and Seaflower Ventures.
20 February 2009•2 mins read
